Iteos Therapeutics IncNASDAQ:ITOS
- LAST PRICE20.9000
- TODAY'S CHANGE (%)0.5100 (2.5012%)
- Bid / Lots20.3000/ 1
- Ask / Lots21.3200/ 2
- Open / Previous Close20.4500 / 20.3900
- Day Range
- 52 Week Range
- Volume171,650
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | ITOS |
|---|---|---|
| 09:32 ET | 1152 | 20.33 |
| 09:33 ET | 300 | 20.8 |
| 09:37 ET | 570 | 20.54 |
| 09:42 ET | 100 | 20.56 |
| 09:46 ET | 100 | 20.675 |
| 09:50 ET | 200 | 20.72 |
| 09:53 ET | 400 | 20.85 |
| 09:55 ET | 100 | 20.85 |
| 09:57 ET | 1412 | 20.8 |
| 10:09 ET | 100 | 20.74 |
| 10:13 ET | 100 | 20.77 |
| 10:18 ET | 3278 | 20.825 |
| 10:20 ET | 4855 | 20.75 |
| 10:27 ET | 100 | 20.86 |
| 10:33 ET | 344 | 20.85 |
| 10:36 ET | 300 | 20.855 |
| 10:38 ET | 735 | 20.9214 |
| 10:42 ET | 200 | 20.855 |
| 10:45 ET | 200 | 20.89 |
| 10:47 ET | 100 | 20.94 |
| 10:49 ET | 100 | 20.89 |
| 10:51 ET | 100 | 20.955 |
| 10:54 ET | 100 | 20.83 |
| 11:00 ET | 100 | 20.875 |
| 11:02 ET | 100 | 20.93 |
| 11:07 ET | 2089 | 20.93 |
| 11:12 ET | 100 | 20.965 |
| 11:14 ET | 200 | 20.96 |
| 11:21 ET | 1308 | 20.94 |
| 11:23 ET | 300 | 21.01 |
| 11:27 ET | 700 | 20.9297 |
| 11:30 ET | 200 | 20.94 |
| 11:34 ET | 100 | 20.91 |
| 11:36 ET | 6500 | 20.85 |
| 11:38 ET | 100 | 21.015 |
| 11:41 ET | 500 | 20.95 |
| 11:43 ET | 200 | 20.965 |
| 11:45 ET | 100 | 20.83 |
| 11:48 ET | 100 | 20.965 |
| 11:54 ET | 100 | 20.84 |
| 11:57 ET | 1300 | 20.83 |
| 11:59 ET | 200 | 20.795 |
| 12:03 ET | 100 | 20.76 |
| 12:06 ET | 226 | 20.76 |
| 12:08 ET | 500 | 20.78 |
| 12:14 ET | 640 | 20.78 |
| 12:15 ET | 100 | 20.855 |
| 12:19 ET | 100 | 20.795 |
| 12:42 ET | 600 | 20.87 |
| 12:44 ET | 100 | 20.965 |
| 12:51 ET | 1000 | 20.845 |
| 12:53 ET | 500 | 20.76 |
| 12:57 ET | 200 | 20.76 |
| 01:06 ET | 100 | 20.815 |
| 01:08 ET | 1100 | 20.9 |
| 01:11 ET | 200 | 20.93 |
| 01:29 ET | 1342 | 20.98 |
| 01:38 ET | 100 | 21.03 |
| 01:40 ET | 200 | 20.94 |
| 01:42 ET | 214 | 20.97 |
| 01:44 ET | 700 | 20.95 |
| 01:47 ET | 1881 | 20.93 |
| 01:51 ET | 100 | 20.93 |
| 01:54 ET | 2330 | 20.89 |
| 01:56 ET | 200 | 20.93 |
| 01:58 ET | 250 | 20.8576 |
| 02:02 ET | 200 | 20.84 |
| 02:09 ET | 600 | 20.82 |
| 02:12 ET | 100 | 20.84 |
| 02:18 ET | 500 | 20.86 |
| 02:20 ET | 800 | 20.815 |
| 02:21 ET | 500 | 20.86 |
| 02:23 ET | 650 | 20.85 |
| 02:32 ET | 100 | 20.81 |
| 02:36 ET | 1300 | 20.78 |
| 02:41 ET | 1291 | 20.78 |
| 02:43 ET | 500 | 20.7301 |
| 02:52 ET | 500 | 20.82 |
| 02:54 ET | 100 | 20.86 |
| 03:01 ET | 100 | 20.9 |
| 03:03 ET | 900 | 20.79 |
| 03:10 ET | 100 | 20.73 |
| 03:12 ET | 100 | 20.76 |
| 03:14 ET | 100 | 20.795 |
| 03:17 ET | 300 | 20.74 |
| 03:19 ET | 300 | 20.72 |
| 03:21 ET | 410 | 20.69 |
| 03:32 ET | 100 | 20.71 |
| 03:33 ET | 100 | 20.71 |
| 03:37 ET | 700 | 20.69 |
| 03:39 ET | 200 | 20.66 |
| 03:44 ET | 100 | 20.65 |
| 03:46 ET | 1110 | 20.62 |
| 03:48 ET | 800 | 20.66 |
| 03:50 ET | 255 | 20.64 |
| 03:51 ET | 1788 | 20.8 |
| 03:53 ET | 300 | 20.81 |
| 03:55 ET | 717 | 20.81 |
| 03:57 ET | 2013 | 20.86 |
| 04:00 ET | 6073 | 20.9 |
Jan 9, 2023
BRIEF-Iteos Announces Cash Runway Into 2026 Through Multiple Inflection Points Across Portfolio, from 8:13AM ET on Monday Jan 09, 2023 by Thomson Reuters
8:13AM ET on Monday Jan 09, 2023 by Thomson ReutersBRIEF-Iteos Provides Business Updates And Clinical Development Plans For 2023, from 8:09AM ET on Monday Jan 09, 2023 by Thomson Reuters
8:09AM ET on Monday Jan 09, 2023 by Thomson ReutersiTeos Provides Business Updates and Clinical Development Plans for 2023, from 7:00AM ET on Monday Jan 09, 2023 by GlobeNewswire
7:00AM ET on Monday Jan 09, 2023 by GlobeNewswire
Jan 3, 2023
iTeos to Present at the 41st Annual J.P. Morgan Healthcare Conference, from 7:00AM ET on Tuesday Jan 03, 2023 by GlobeNewswire
7:00AM ET on Tuesday Jan 03, 2023 by GlobeNewswireiTeos to Present at the 41st Annual J.P. Morgan Healthcare Conference, from 7:00AM ET on Tuesday Jan 03, 2023 by Thomson Reuters ONE
7:00AM ET on Tuesday Jan 03, 2023 by Thomson Reuters ONE
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Iteos Therapeutics Inc | 725.4M | 3.1x | --- |
Intercept Pharmaceuticals Inc | 743.0M | -3.0x | --- |
Coherus BioSciences Inc | 633.1M | -2.4x | --- |
Agenus Inc | 722.1M | -3.3x | --- |
CareDx Inc | 784.3M | -10.7x | --- |
Atea Pharmaceuticals Inc | 384.0M | 12.9x | --- |
Company Information
iTeos Therapeutics Inc. is a clinical-stage biopharmaceutical company. The Company is focused on the discovery and development of differentiated immuno-oncology therapeutics for patients with cancer. The Company's pipeline includes two clinical-stage programs: EOS-448 and Inupadenant. The Company’s lead antibody product candidate, EOS-448, is an antagonist of T-cell immunoreceptor with Ig and ITIM domains (TIGIT), an immune checkpoint with multiple mechanisms of action, which leads to immunosuppression. Its inupadenant, is an adenosine A2A receptor antagonist tailored to overcome the specific adenosine-mediated immunosuppression found in tumor microenvironment. The Company is conducting an open-label multi-arm Phase I/IIa clinical trial of inupadenant in adult cancer patients with advanced solid tumors.
Contact Information
- Headquarters
- 321 Arsenal Street Bldg 312, Floor 3, Suite 301WATERTOWN, MA, United States 02472
- Phone
- 857-204-4583
- Fax
- 302-655-5049
Executives
- Non-Executive Independent Chairman of the Board
- David Hallal
- Chief Executive Officer, Director
- Michel Detheux
- Chief Financial Officer
- Matthew Gall
- Chief Operating Officer
- Matthew Call
- Chief Scientific Officer
- Yvonne Mcgrath
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $725.4M |
|---|---|
Revenue (TTM) | $454.2M |
Shares Outstanding | 35.6M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | --- |
EPS | $6.80 |
Book Value | $15.59 |
P/E Ratio | 3.1x |
Price/Sales (TTM) | 1.6 |
Price/Cash Flow (TTM) | 2.8x |
Operating Margin | 70.99% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
